Please use this identifier to cite or link to this item:
https://ahro.austin.org.au/austinjspui/handle/1/20840| Title: | Editorial: Cancer Plasticity and the Microenvironment: Implications for Immunity and Therapy Response. | Austin Authors: | Behren, Andreas;Thompson, Erik W;Anderson, Robin L ;Ferrao, Petranel T | Affiliation: | Translational Breast Cancer Program, Olivia Newton-John Cancer Research Institute, Heidelberg, Victoria, Australia Cancer Immunobiology Program, Olivia Newton-John Cancer Research Institute, Heidelberg, Victoria, Australia Institute of Health and Biomedical Innovation and School of Biomedical Sciences, Queensland University of Technology, and The Translational Research Institute, Brisbane, QLD, Australia Clinical Pathology and Surgery, The University of Melbourne, Melbourne, Victoria, Australia School of Cancer Medicine, La Trobe University, Heidelberg, Victoria, Australia |
Issue Date: | 7-May-2019 | Date: | 2019-05-07 | Publication information: | Frontiers in Oncology 2019; 9: 276 | URI: | https://ahro.austin.org.au/austinjspui/handle/1/20840 | DOI: | 10.3389/fonc.2019.00276 | ORCID: | 0000-0001-5329-280X 0000-0002-6841-7422 |
Journal: | Frontiers in Oncology | PubMed URL: | 31134142 | ISSN: | 2234-943X | Type: | Journal Article | Subjects: | cancer plasticity epithelial-to-mesenchymal transition (EMT) heterogeneity immune checkpoint inhibitors immune evasion immunotherapy therapy resistance tumor microenvironment (TME) |
| Appears in Collections: | Journal articles |
Show full item record
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.